Conference Coverage

Conference Coverage Videos

Complete Conference Coverage

Multidisciplinary Cancer Teams Lack Information on Patients' Comborbidity

Multidisciplinary Cancer Teams Lack Information on Patients' Comborbidity

Multidisciplinary cancer team meetings need to systematically consider treatment of patients with comorbidity.

Tumor-Specific Differences, Genomic Alterations of Biliary Tract Cancers Identified

Tumor-Specific Differences, Genomic Alterations of Biliary Tract Cancers Identified

Gastrointestinal cancers have a diverse landscape of clinically relevant genomic alterations (CRGA) that could lead to targeted drug therapy.

eNOS Polymorphisms May Influence Prognosis in Hepatocellular Carcinoma Treated with Sorafenib

eNOS Polymorphisms May Influence Prognosis in Hepatocellular Carcinoma Treated with Sorafenib

Endothelial nitric oxide synthase (eNOS) VNTR and eNOS -786 could determine outcomes in advanced hepatocellular carcinoma treated with sorafenib,

In Advanced Hepatocellular Carcinoma, Baseline AFP May Predict Response to Ramucirumab

In Advanced Hepatocellular Carcinoma, Baseline AFP May Predict Response to Ramucirumab

Baseline α-fetoprotein (AFP) levels may be a predictive marker for advanced hepatocellular carcinoma receiving ramucirumab.

Similarities, Differences Between Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas

Similarities, Differences Between Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas

Comprehensive genomic profiling (CGP) shows promise in advanced esophageal squamous cell carcinomas (ESCC) and adenocarcinoma (EAC).

Hybrid Minimally Invasive Oesophagectomy Use for Oesophageal Cancer Supported

Hybrid Minimally Invasive Oesophagectomy Use for Oesophageal Cancer Supported

Hybrid minimally invasive oesophagectomy (HMIO) is associated with fewer complications for resectable oesphageal cancer.

Laproscopically Assisted Distal Gastrectomy Safe for Stage 1 Gastric Cancer

Laproscopically Assisted Distal Gastrectomy Safe for Stage 1 Gastric Cancer

Laproscopically assisted distal gastrectomy (LADG) is safe for patients with clinical stage 1 gastric cancer.

Pembrolizumab Shows Antitumor Activity, Manageable Toxicity in Advanced Gastric Cancer

Pembrolizumab Shows Antitumor Activity, Manageable Toxicity in Advanced Gastric Cancer

Pembrolizumab demonstrated promising antitumor activity and manageable toxicity in advanced gastric cancer.

For Gastroesophageal Adenocarcinoma, Addition of Onartuzumab to FOLFOX Does Not Improve Survival

For Gastroesophageal Adenocarcinoma, Addition of Onartuzumab to FOLFOX Does Not Improve Survival

Addition of onartuzumab to mFOLFOX6 for gastroesophageal adenocarcinoma (GEC) did not improve survival.

AMG-337 May Be Effective for MET-Amplified Gastrointestinal Tumors

AMG-337 May Be Effective for MET-Amplified Gastrointestinal Tumors

AMG-337 caused responses in patients with MET-amplified gastroesophageal junction, gastric cancer, and esophageal cancer.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs